Impact of Tourniquet Use on Rocuronium Paralysis Duration in Lower Limb Fracture Surgery
Overview
This study evaluated how tourniquet application affects the duration of rocuronium-induced muscle paralysis during ankle and hindfoot fracture surgeries. Findings demonstrated prolonged paralysis distal to the tourniquet compared to proximal sites, indicating that facial nerve monitoring may not accurately reflect neuromuscular blockade in the operative limb.
Background
Tourniquets are commonly used in lower limb fracture surgeries to reduce blood loss and improve surgical visualization. Muscle paralysis with agents like rocuronium facilitates fracture reduction and joint manipulation. However, the influence of tourniquet inflation on the pharmacodynamics of neuromuscular blockers remains unclear. Understanding this relationship is critical for accurate neuromuscular monitoring and dosing during surgery.
Data Highlights
Parameter
Value
Number of patients analyzed
25
Mean age (years)
38.8 (range 22–72)
Average BMI
29.9 (range 22.5–38.5)
Fracture types
17 ankles, 1 calcaneus, 7 pilon
Average initial rocuronium dose (mg)
57.9 (range 50–100)
Average time to regain ≥1 twitch (facial nerve)
34.5 minutes
Patients with ≥3 facial twitches before extremity twitches
19 (76%)
Patients with extremity twitch recovery before facial nerve
6 (24%)
Patients with ≤2 twitches in extremity during tourniquet inflation
19 (76%)
Key Findings
Rocuronium-induced paralysis lasted longer distal to the tourniquet compared to proximal sites.
Facial nerve monitoring often showed recovery of twitches before any twitches returned in the operative extremity.
76% of patients had 3 or more facial twitches before any twitch was detected distal to the tourniquet.
No rocuronium re-dosing was required during tourniquet inflation despite facial twitch recovery.
Neuromuscular monitoring distal to the tourniquet is essential for accurate assessment of paralysis depth in the operative limb.
Patient demographics and fracture type did not significantly affect twitch recovery times.
Clinical Implications
Clinicians should be aware that neuromuscular blockade monitoring via the facial nerve may underestimate paralysis duration in the limb distal to a tourniquet. Redosing rocuronium based solely on facial nerve twitch recovery during tourniquet inflation may be unnecessary and could lead to overdosing. Monitoring neuromuscular function distal to the tourniquet provides a more accurate assessment to guide paralytic management during surgery.
Conclusion
Tourniquet inflation prolongs rocuronium paralysis distal to the cuff, causing discordance between proximal and distal neuromuscular monitoring sites. This finding supports the need for distal monitoring to optimize paralytic dosing and patient safety during lower limb fracture surgeries.
References
Anesthesia Patient Safety Foundation (APSF) -- Neuromuscular Monitoring Guidelines
Study Authors, 2024 -- Impact of Tourniquet Application on Rocuronium Administration in Lower Limb Fracture Surgery
Supervised rehabilitation and exercise-based therapies may improve function, pain, and bone health in ankylosing spondylitis, according to a new review.
